Gurol-Urganci Ipek, de Jongh Thyra, Vodopivec-Jamsek Vlasta, Atun Rifat, Car Josip
Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Cochrane Database Syst Rev. 2013 Dec 5;2013(12):CD007458. doi: 10.1002/14651858.CD007458.pub3.
This review is an update of the original Cochrane review published in July 2012. Missed appointments are a major cause of inefficiency in healthcare delivery with substantial monetary costs for the health system, leading to delays in diagnosis and appropriate treatment. Patients' forgetfulness is one of the main reasons for missed appointments. Patient reminders may help reduce missed appointments. Modes of communicating reminders for appointments to patients include face-to-face communication, postal messages, calls to landlines or mobile phones, and mobile phone messaging. Mobile phone messaging applications, such as Short Message Service (SMS) and Multimedia Message Service (MMS), could provide an important, inexpensive delivery medium for reminders for healthcare appointments.
To update our review assessing the effects of mobile phone messaging reminders for attendance at healthcare appointments. Secondary objectives include assessment of costs; health outcomes; patients' and healthcare providers' evaluation of the intervention and perceptions of safety; and possible harms and adverse effects associated with the intervention.
Original searches were run in June 2009. For this update, we searched the Cochrane Central Register of Controlled Trials (CENTRAL,The Cochrane Library 2012, Issue 8), MEDLINE (OvidSP) (January 1993 to August 2012), EMBASE (OvidSP) (January 1993 to August 2012), PsycINFO (OvidSP) (January 1993 to August 2012) and CINAHL (EbscoHOST) (January 1993 to August 2012). We also reviewed grey literature (including trial registers) and reference lists of articles.
Randomised controlled trials (RCTs) assessing mobile phone messaging as reminders for healthcare appointments. We only included studies in which it was possible to assess effects of mobile phone messaging independent of other technologies or interventions.
Two review authors independently assessed all studies against the inclusion criteria, with any disagreements resolved by a third review author. Study design features, characteristics of target populations, interventions and controls, and results data were extracted by two review authors and confirmed by a third author. Two authors assessed the risk of bias of the included studies. As the intervention characteristics and outcome measures were similar across included studies, we conducted a meta-analysis to estimate an overall effect size.
We included eight randomised controlled trials involving 6615 participants. Four of these studies were newly identified during this update.We found moderate quality evidence from seven studies (5841 participants) that mobile text message reminders improved the rate of attendance at healthcare appointments compared to no reminders (risk ratio (RR) 1.14 (95% confidence interval (CI) 1.03 to 1.26)). There was also moderate quality evidence from three studies (2509 participants) that mobile text message reminders had a similar impact to phone call reminders (RR 0.99 (95% CI 0.95 to 1.02). Low quality evidence from one study (291 participants) suggests that mobile text message reminders combined with postal reminders improved the rate of attendance at healthcare appointments compared to postal reminders alone (RR 1.10 (95% CI 1.02 to 1.19)). Overall, the attendance to appointment rates were 67.8% for the no reminders group, 78.6% for the mobile phone messaging reminders group and 80.3% for the phone call reminders group. One study reported generally that there were no adverse effects during the study period; none of the studies reported in detail on specific adverse events such as loss of privacy, data misinterpretation, or message delivery failure. Two studies reported that the costs per text message per attendance were respectively 55% and 65% lower than costs per phone call reminder. The studies included in the review did not report on health outcomes or people's perceptions of safety related to receiving reminders by text message.
AUTHORS' CONCLUSIONS: Low to moderate quality evidence included in this review shows that mobile phone text messaging reminders increase attendance at healthcare appointments compared to no reminders, or postal reminders.Text messaging reminders were similar to telephone reminders in terms of their effect on attendance rates, and cost less than telephone reminders. However, the included studies were heterogeneous and the quality of the evidence therein is low to moderate. Further, there is a lack of information about health effects, adverse effects and harms, user evaluation of the intervention and user perceptions of its safety. The current evidence therefore still remains insufficient to conclusively inform policy decisions.There is a need for more high-quality randomised trials of mobile phone messaging reminders, that measure not only patients' attendance rates, but also focus on the cost-effectiveness of these interventions. Health outcomes, patients' and healthcare providers' evaluation and perceptions of the safety of the interventions, potential harms, and adverse effects of mobile phone messaging reminders should be assessed. Studies should report message content and timing in relation to the appointment.
本综述是对2012年7月发表的原始Cochrane综述的更新。失约是医疗服务效率低下的主要原因,给卫生系统带来了巨大的金钱成本,导致诊断和适当治疗的延迟。患者遗忘是失约的主要原因之一。患者提醒可能有助于减少失约。向患者传达预约提醒的方式包括面对面沟通、邮政信件、拨打固定电话或手机以及手机短信。手机短信应用程序,如短消息服务(SMS)和多媒体消息服务(MMS),可以为医疗预约提醒提供一种重要且廉价的传递媒介。
更新我们对手机短信提醒对医疗预约就诊影响的综述。次要目的包括成本评估;健康结果;患者和医疗服务提供者对干预的评价以及对安全性的认知;以及与干预相关的可能危害和不良反应。
原始检索于2009年6月进行。本次更新时,我们检索了Cochrane对照试验中心注册库(CENTRAL,《Cochrane图书馆》2012年第8期)、MEDLINE(OvidSP)(1993年1月至2012年8月)、EMBASE(OvidSP)(1993年1月至2012年8月)、PsycINFO(OvidSP)(1993年1月至2012年8月)和CINAHL(EbscoHOST)(1993年1月至2012年8月)。我们还查阅了灰色文献(包括试验注册库)和文章的参考文献列表。
评估手机短信作为医疗预约提醒的随机对照试验(RCT)。我们仅纳入了能够独立于其他技术或干预措施评估手机短信效果的研究。
两位综述作者根据纳入标准独立评估所有研究,如有分歧则由第三位综述作者解决。研究设计特征、目标人群特征、干预措施和对照以及结果数据由两位综述作者提取,并由第三位作者确认。两位作者评估了纳入研究的偏倚风险。由于纳入研究的干预特征和结局测量相似,我们进行了荟萃分析以估计总体效应大小。
我们纳入了八项随机对照试验,涉及6615名参与者。其中四项研究是在本次更新过程中新发现的。我们从七项研究(5841名参与者)中发现了中等质量的证据,表明与无提醒相比,手机短信提醒提高了医疗预约的就诊率(风险比(RR)1.14(95%置信区间(CI)1.03至1.26))。三项研究(2509名参与者)也提供了中等质量的证据,表明手机短信提醒与电话提醒的影响相似(RR 0.99(95%CI 0.95至1.02))。一项研究(291名参与者)的低质量证据表明,与单独的邮政提醒相比,手机短信提醒与邮政提醒相结合提高了医疗预约的就诊率(RR 1.10(95%CI 1.02至1.19))。总体而言,无提醒组的预约就诊率为67.8%,手机短信提醒组为78.6%,电话提醒组为80.3%。一项研究总体报告称,研究期间没有不良反应;没有研究详细报告特定的不良事件,如隐私泄露、数据误解或消息传递失败。两项研究报告称,每次就诊的短信成本分别比电话提醒成本低55%和65%。综述中纳入的研究未报告健康结果或人们对通过短信接收提醒的安全性认知。
本综述中纳入的低至中等质量的证据表明,与无提醒或邮政提醒相比,手机短信提醒提高了医疗预约的就诊率。短信提醒在对就诊率的影响方面与电话提醒相似,且成本低于电话提醒。然而,纳入的研究具有异质性,其中证据的质量为低至中等。此外,缺乏关于健康影响、不良反应和危害、用户对干预的评价以及用户对其安全性的认知的信息。因此,目前的证据仍然不足以最终为政策决策提供依据。需要更多高质量的手机短信提醒随机试验,这些试验不仅要测量患者的就诊率,还要关注这些干预措施的成本效益。应评估健康结果、患者和医疗服务提供者对干预安全性的评价和认知、潜在危害以及手机短信提醒的不良反应。研究应报告与预约相关的消息内容和时间安排。